Growth Hormone-Releasing Factor (GRF), also known as growth hormone-releasing hormone (GHRH), is a hypothalamic peptide that acts on the pituitary somatotroph cells to stimulate the synthesis and pulsatile release of endogenous growth hormone (GH), which is both anabolic and lipolytic
PlexusDx can help identify whether your genetic background suggests strong responsiveness to GLP-1 therapy through the Precision Peptide Genetic Test, which analyzes pathways like GLP1R rs6923761 that influence medication effectiveness
Hormonal fluctuations affect GLP-1 sensitivity across the menstrual cycle
The most commonly reported include gastrointestinal disturbances such as nausea, diarrhoea, abdominal discomfort, and loss of appetite
Recommended Use: Take 1 serving (2 capsules) daily, preferably before a meal
GLP-1 weight loss injection treatments near Columbia, Maryland target appetite hormones to help patients achieve sustained results